Financial Daily from THE HINDU group of publications
Saturday, Feb 19, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Markets - Stock Markets
Columns - Ear to the ground


SWIL upbeat on takeover buzz

Virendra Verma

COPPER company SWIL was locked in 20 per cent upper circuit on Friday. The stock closed at Rs 17.47 on the BSE with volume of 46.83 lakh shares.

Dealers said the sudden interest in the stock came on market talk that a leading non-ferrous company would acquire the company. They said several metal companies in the past have also shown interest in buying the company. Currently, financial institutions run the company and in the past also they have tried to sell the company but nothing concrete has happened.

However, dealers said, with the outlook for copper sector looking bright, the financial institutions might get a good price this time. Company officials were not available for comments.

Gains on `buy' report

SHARES of Nobel Explochem, a specialty chemical and industrial explosive company, are on an upward move in the last few days. In fact, it has gained almost 45 per cent in the last one month. On Friday also the stock was locked in 10 per cent upper circuit and closed at Rs 46.05 on the BSE with volume of 9.57 lakh shares.

Dealers said the rise in the stock price is after a domestic broking firm came out with a buy report on the stock. Talks are that the company's specialty chemicals and industrial oxygen business is doing well. Its industrial explosive business is likely to grow by more than 25 per cent in the next three years. Moreover, the demand for its specialty chemicals within the industrial segment is also expected to show steady growth. The company has also grown various cash crops around its 300 acres of factory land with investment of Rs 5 crore. The market talk is that the cash crops will also help the company improve the profit margins in the next couple of years. However, its contributions to the overall topline and bottomline will not be very large.

Spurred by cancer drug

THE stock of Zenotech Laboratories, formerly Sunline Technologies, have been locked in upper circuit in the last few trading sessions.

Dealers said several market players have started showing interest in the stock. Interest in this stock has surfaced on indication that the company is developing a drug for treatment of cancer and the future for this drug is bright.

Dealers said the company is likely to bring down the cost of this drug sharply in the next one year when it starts the commercial launch of it. Several market players have bought big stake in the company. On Friday, the stock of the company closed at Rs 140.15, up 5 per cent, with volume of 2.56 lakh shares.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
Kotak Mahindra Bank makes pref allotment


Merven Drug plans preferential issue
Financial Tech okays pref allotment to 2 FIIs
S Kumars board to decide on pref allotment
Crisil board backs S&P's open offer
Fidelity gets SEBI nod to launch MF in India
Pantaloon to pick up 15.73 pc in Galaxy
Range-bound movement
SWIL upbeat on takeover buzz
Paper stocks move up on price rise expectation
Outlook may turn positive for ITC, Tata Tea
Damodaran takes charge at SEBI — `Swift, heavy punishment for mischief makers in market'
Thanks to SEBI's revised listing norms — Consulting firms flooded with risk management assignments
Weak trend persists in large, mid-cap stocks
Jet Air IPO subscribed 4.25 times on first day
United Western Bank plans public issue
Deloitte to advise PNB on UK subsidiary — Bank's second public offer to open on March 7


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line